mTOR Activity and Autophagy in Senescent Cells, a Complex Partnership

Area of Science:

• Cellular and Molecular Biology
• Oncology
• Metabolism

Background:

• Cellular senescence is a state of irreversible cell cycle arrest with distinct morphological and functional changes.
• Senescent cells exhibit a senescence-associated secretory phenotype (SASP) with pro-inflammatory and pro-tumorigenic properties.
• The mTOR pathway and autophagy are implicated in regulating senescence and SASP, but their precise roles are context-dependent.

Purpose of the Study:

• To investigate the intricate relationship between cellular senescence, the mTOR pathway, and autophagy.
• To elucidate how these metabolic pathways influence the senescence-associated secretory phenotype (SASP).
• To explore the potential for combinatorial therapies targeting senescence, mTOR, and autophagy in cancer treatment.

Main Methods:

• Analysis of cellular senescence markers and morphology.
• Investigation of mTOR signaling pathway activity.
• Assessment of autophagy flux and its regulation.
• Evaluation of SASP component production.

Main Results:

• Cellular senescence is associated with significant alterations in mTOR activity and autophagy.
• Autophagy appears upregulated in senescent cells, potentially independently of canonical mTOR repression.
• Autophagy may provide substrates for mTORC1, supporting SASP component synthesis.
• mTOR inhibition can have varied effects on senescence, including reversal, quiescence, or cell death.

Conclusions:

• The interplay between mTOR and autophagy in senescent cells differs from non-senescent contexts.
• Targeting these metabolic pathways offers potential for novel anti-cancer strategies.
• Combinatorial therapies involving senolytics, mTOR inhibitors, and autophagy inhibitors warrant further investigation.